Suppr超能文献

选择性降解允许反馈环控制 NPC1 突变细胞内溶酶体中的膜联蛋白 A6 和胆固醇水平。

Selective Degradation Permits a Feedback Loop Controlling Annexin A6 and Cholesterol Levels in Endolysosomes of NPC1 Mutant Cells.

机构信息

Departament de Biomedicina, Unitat de Biologia Cel·lular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, 08036 Barcelona, Spain.

Centre de Recerca Biomèdica CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036-Barcelona, Spain.

出版信息

Cells. 2020 May 7;9(5):1152. doi: 10.3390/cells9051152.

Abstract

We recently identified elevated annexin A6 (AnxA6) protein levels in Niemann-Pick-type C1 (NPC1) mutant cells. In these cells, AnxA6 depletion rescued the cholesterol accumulation associated with NPC1 deficiency. Here, we demonstrate that elevated AnxA6 protein levels in NPC1 mutants or upon pharmacological NPC1 inhibition, using U18666A, were not due to upregulated AnxA6 mRNA expression, but caused by defects in AnxA6 protein degradation. Two KFERQ-motifs are believed to target AnxA6 to lysosomes for chaperone-mediated autophagy (CMA), and we hypothesized that the cholesterol accumulation in endolysosomes (LE/Lys) triggered by the NPC1 inhibition could interfere with the CMA pathway. Therefore, AnxA6 protein amounts and cholesterol levels in the LE/Lys (LE-Chol) compartment were analyzed in NPC1 mutant cells ectopically expressing lysosome-associated membrane protein 2A (Lamp2A), which is well known to induce the CMA pathway. Strikingly, AnxA6 protein amounts were strongly decreased and coincided with significantly reduced LE-Chol levels in NPC1 mutant cells upon Lamp2A overexpression. Therefore, these findings suggest Lamp2A-mediated restoration of CMA in NPC1 mutant cells to lower LE-Chol levels with concomitant lysosomal AnxA6 degradation. Collectively, we propose CMA to permit a feedback loop between AnxA6 and cholesterol levels in LE/Lys, encompassing a novel mechanism for regulating cholesterol homeostasis in NPC1 disease.

摘要

我们最近发现 NPC1 突变细胞中 Annexin A6(AnxA6)蛋白水平升高。在这些细胞中,AnxA6 耗竭挽救了与 NPC1 缺乏相关的胆固醇积累。在这里,我们证明 NPC1 突变体或在用 U18666A 进行药理学 NPC1 抑制时,AnxA6 蛋白水平升高不是由于 AnxA6 mRNA 表达上调,而是由于 AnxA6 蛋白降解缺陷所致。两个 KFERQ 基序被认为将 AnxA6 靶向溶酶体进行伴侣介导的自噬(CMA),我们假设 NPC1 抑制引起的内溶酶体(LE/Lys)中的胆固醇积累可能会干扰 CMA 途径。因此,在异位表达溶酶体相关膜蛋白 2A(Lamp2A)的 NPC1 突变细胞中分析了 LE/Lys(LE-Chol)隔室中的 AnxA6 蛋白量和胆固醇水平,Lamp2A 众所周知可诱导 CMA 途径。引人注目的是,在 Lamp2A 过表达时,NPC1 突变细胞中的 AnxA6 蛋白量强烈减少,并伴有 LE-Chol 水平显著降低。因此,这些发现表明 Lamp2A 介导的 NPC1 突变细胞中的 CMA 恢复可降低 LE-Chol 水平,同时伴有溶酶体 AnxA6 降解。总的来说,我们提出 CMA 允许 LE/Lys 中 AnxA6 和胆固醇水平之间的反馈回路,包含 NPC1 疾病中调节胆固醇稳态的新机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8f5/7291204/423652444a73/cells-09-01152-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验